✦ LIBER ✦

A 12-Month Clinical Study of LA-2585 (45.0 MG): A New 6-Month Subcutaneous Delivery System for Leuprolide Acetate for the Treatment of Prostate Cancer

✍ Scribed by Crawford, E. David; Sartor, Oliver; Chu, Franklin; Perez, Ramon; Karlin, Gary; Garrett, J. Steve

Book ID: 121779347
Publisher: Lippincott Williams and Wilkins
Year: 2006
Tongue: English
Weight: 130 KB
Volume: 175
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)00161-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An eight-month clinical study of LA-2575

An eight-month clinical study of LA-2575 30.0 mg: a new 4-month, subcutaneous delivery system for leuprolide acetate in the treatment of prostate cancer

✍ Oliver Sartor; Martin K Dineen; Ramon Perez-Marreno; Franklin M Chu; Graham J Ca 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A Clinical Study Of 22.5 mg. La-2550: A

A Clinical Study Of 22.5 mg. La-2550: A New Subcutaneous Depot Delivery System For Leuprolide Acetate For The Treatment Of Prostate Cancer

✍ Chu, Franklin M.; Jayson, Maury; Dineen, Martin K.; Perez, Ramon; Harkaway, Rich 📂 Article 📅 2002 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 161 KB

A subcutaneous delivery system for the e

A subcutaneous delivery system for the extended release of leuprolide acetate for the treatment of prostate cancer

✍ Perez-Marrero, Ramon; Tyler, Robert C 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 175 KB

Clinical development of a new pharmaceut

Clinical development of a new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Studies of a 1-month implant

✍ Thyroff-Friesinger⁎, U.; Geiges, G.; Engert, Z. Vendel 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 79 KB

Clinical development of a new pharmaceut

Clinical development of a new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Studies of a 3-month implant

✍ Thyroff-Friesinger⁎, U.; Geiges, G.; Engert, Z. Vendel 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 64 KB

Clinical development of a new pharmaceut

Clinical development of a new pharmaceutical form of leuprorelin acetate for the treatment of advanced prostate cancer: Pharmacokinetics of a 3-month implant

✍ Thyroff-Friesinger⁎, U.; Geiges, G.; Engert, Z. Vendel 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 68 KB